Skip to main content

Advertisement

Table 4 Chemotherapy response assessment

From: Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer

  Differentiation status PLR NLR cNPS cNPLDS
well/moderate poor ≤223 > 223 ≤3.04 > 3.04 1 2 3 1–2 3–4 6–9
Total 46 90 89 47 81 55 69 32 35 27 55 54
CR 0
(0%)
0
(0%)
0
(0%)
0
(0%)
0
(0%)
0
(0%)
0
(0%)
0
(0%)
0
(0%)
0
(0%)
0
(0%)
0
(0%)
PR 3
(6.52%)
4
(4.44%)
4
(4.49%)
3
(6.38%)
3
(3.70%)
4
(7.27%)
2
(2.90%)
3
(9.38%)
2
(5.71%)
2
(7.41%)
1
(1.82%)
4
(7.41%)
SD 36
(78.26%)
64
(71.11%)
72
(80.89%)
28
(59.57%)
68
(83.95%)
32
(58.18%)
59
(85.51%)
22
(68.75%)
17
(48.57%)
23
(85.19%)
46
(83.64%)
31
(57.41%)
PD 7
(15.21%)
22
(24.44%)
13
(14.61%)
16
(34.04%)
10
(12.34%)
19
(34.55%)
8
(11.59%)
7
(21.87%)
14
(40%)
2
(7.41%)
8
(14.55%)
19
(35.19%)
DCR 84.78% 75.56% 85.39% 65.96% 87.65% 65.45% 88.40% 78.13% 60% 92.59% 85.45% 64.81%
P 0.214 0.008 0.002 0.004 0.004